Pharmafile Logo

Webinar: Ensuring an actionable segmentation

March 31, 2015 |  

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable. Even the best constructed and well observed segmentation solution will fall down if people within your company don’t adopt it, and the most detailed and comprehensive (and expensive) segmentation is of no use if it isn’t implemented.

In this webinar, quantitative experts Duncan Munro and Jennifer Redfearn, utilise knowledge and experience garnered from more than 15 years of conducting global segmentations for pharma, to explore the following key segmentation challenges:

  • Conducting global segmentations
    The benefits and potential pitfalls of conducting global segmentation research
  • Encouraging internal buy-in
    Examining the best techniques to ensure that a segmentation is adopted by key internal stakeholders.
  • Ensuring sales force execution
    Identifying the key challenges that prevent successful execution and explore the ways in which researchers can overcome these issues and ensure an actionable segmentation   
  • Answer your segmentation questions

To view this webinar please visit http://bit.ly/1C4QKwL

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.